Direct-to-Consumer Genetic Testing: The Implications of the US FDA's First Marketing Authorization for BRCA Mutation Testing

JAMA. 2018 Jun 19;319(23):2377-2378. doi: 10.1001/jama.2018.5330.
No abstract available

MeSH terms

  • Breast Neoplasms / ethnology
  • Breast Neoplasms / genetics
  • Direct-To-Consumer Screening and Testing* / legislation & jurisprudence
  • Female
  • Genes, BRCA1*
  • Genes, BRCA2*
  • Genetic Counseling / statistics & numerical data
  • Genetic Testing / legislation & jurisprudence*
  • Government Regulation
  • Humans
  • Marketing / legislation & jurisprudence*
  • Medical Overuse
  • Mutation*
  • Predictive Value of Tests
  • United States
  • United States Food and Drug Administration